Press Release

Sint-Denijs-Westrem, 7 October 2025

Ceres Pharma NV, a Belgian based pharmaceutical company with a strong foothold in Belgium, Italy, and Central and Eastern Europe, has acquired* 100% of the shares in the Hungarian company BioCo Kft.

BioCo Kft. is a family-owned company active in the development, production and distribution of innovative and high-quality food supplements under its own BioCo® brand in Hungary. The BioCo® brand is the third largest food supplement brand in Hungarian pharmacies, covering more than 90% of the Hungarian pharmacies. The BioCo® brand also holds a strong position in the two largest drugstore chains dm and Rossmann, as well as  the largest health food store chains in Hungary. In 2024, BioCo achieved a turnover of 8.5 million euros. 

"I am very happy that we have reached an agreement with the owners of BioCo. This acquisition fits perfectly within Ceres Pharma’s strategy. BioCo will reinforce our position in Hungary, particularly in the pharmacies; the brands and sales channels of BioCo and Ceres Pharma Hungary complement each other very well. Furthermore, we can sell BioCo's products in our other countries and also produce some other products at BioCo's GMP-certified manufacturing plant.”, says Mario Debel, CEO of Ceres Pharma.

“We are delighted to join Ceres Pharma, a strong, dynamic and fast-growing international group. Together, we will be stronger to execute our ambitious growth plan in Hungary and beyond.",  says Nikolett Urbán, owner and Managing Director of BioCo.

The two Managing Directors, Nikolett Urbán and Judit Szép, will remain on board to continue managing BioCo’s manufacturing plant and driving innovation within Ceres Pharma Hungary. The price of the acquisition will not be disclosed.

About BioCo

BioCo is a family-owned company active in the development, production and distribution of innovative and high-quality food supplements under its own BioCo® brand in Hungary.

About Ceres Pharma                                                                                                                                               

Ceres Pharma is a dynamic and fast growing, Belgian based, pharmaceutical company, founded in 2017 by Mario Debel and Alychlo and acquired in 2021 by Naxicap Partners. It is the ambition of Naxicap and the founder and CEO Mario Debel to grow Ceres Pharma through the development of its own product portfolio as well as through acquisitions. Ceres Pharma is active in the development, production and distribution of drugs, medical devices, biocides, cosmetics, high-quality food supplements and pharmaceutical preparations in Belgium, Italy and in Central and Eastern Europe.

About Naxicap Partners                                                                                                                                                 

As one of the top private equity firms in France, Naxicap Partners - an affiliate of Natixis Investment Managers - has 6.7 billion euros in assets under management as of 31 December 2022. As a committed, responsible investor, Naxicap Partners builds solid, constructive partnerships with entrepreneurs so that their projects can succeed. The firm has more than 100 investment professionals spread across six offices in Paris, Lyon, Toulouse, Nantes, Frankfurt and Zurich.

*Subject to approval by the relevant regulatory authorities.